Overview
Corporate Profile
Kips Bay Medical, Inc. was founded in 2007 to develop innovative vascular technology for the cardiac surgeon. We are a medical device company currently focused on manufacturing and commercializing a compelling technology, the eSVS Mesh, which is an external support device for saphenous veins used as bypass conduits in coronary artery bypass grafting (CABG) surgery.

The Kips Bay Medical eSVS Mesh is designed to address the limitations of saphenous vein grafts, or SVGs, used in CABG surgery. The eSVS Mesh is fitted like a sleev... 
More >>
Stock Quote
KIPS (Common Stock)
PriceChange% ChangeVolume
$0.400.000.00%46,614
Exchange: NASDAQ (US Dollar)
Financial Status Indicator: D
08/22/14 2:32 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
08/12/14Kips Bay Medical Provides Feasibility Study Update and Reports Second Quarter 2014 Results
MINNEAPOLIS, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (Nasdaq:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its second quarter ended June 28, 2014. Enrollment Begins at Lenox Hill Hospital in New York The Company recently announced that on July 17, 2014,... 
Printer Friendly Version
07/28/14Kips Bay Medical Announces the First eSVS Mesh Implant by Lenox Hill Hospital of New York
MINNEAPOLIS, July 28, 2014 (GLOBE NEWSWIRE) -- Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (Nasdaq:KIPS), announced that on July 17, 2014, Lenox Hill Hospital in New York City performed its first implant of an eSVS® Mesh. This implant was performed as part of the Kips Bay Medical eMESH I clinical feasibility trial currently being conducted for the U.S. Food and Drug Administration (FDA) in a number of preeminent cardiac surgery centers in both Europe and the United States. The... 
Printer Friendly Version
05/14/14World Renowned Heart Surgeon, Dr. Larry Cohn, Joins Kips Bay Medical as a Medical Advisor
MINNEAPOLIS, May 14, 2014 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (Nasdaq:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting surgery, today announced that Lawrence H. Cohn, M.D. has been engaged as a consultant to provide medical advisory services. "We're excited to have such an accomplished and distinguished heart surgeon join our team as an advisor who can help us... 
Printer Friendly Version
05/08/14Kips Bay Medical Provides Business Update and Reports First Quarter 2014 Results
MINNEAPOLIS, May 8, 2014 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (Nasdaq:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its first quarter ended March 29, 2014. Expanded IDE Approval for U.S. Study Work As previously announced, in March 2014, the United States Food & Drug Ad... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.

Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | Financial Tear Sheet Tear Sheet